FCSSOFTNSEFCS Software Solutions Limited· Computers - SoftwareLowNeutral
Announced Thu, 24 Jul · 12:12 IST

FCS Software Solutions Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 19, 2025

Board & Shareholder Meetings View source PDF

FCSSOFT · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

FCS Software Solutions has informed the exchanges about its 32nd AGM scheduled for Tuesday, August 19, 2025 at 11:30 AM via video conferencing. Key items on the agenda include adoption of audited standalone and consolidated financial statements for FY ended March 31, 2025, and re-appointment of Mrs. Neelam Sharma (wife of CMD Mr. Dalip Kumar) as Non-Executive Director, who retires by rotation. The meeting will also consider regularization of two newly appointed independent directors — Ms. Dolly Saini (5-year term from May 2025) and Mr. Nitish Kumar Singh (5-year term from July 2025) — and the appointment of M/s Neeraj Arora & Associates as Secretarial Auditor for five consecutive years from FY 2025-26 to FY 2029-30. Additionally, shareholders' approval is sought for material related party transactions with Bloom Healthcare & Hospitality Management Pvt. Ltd. (a material subsidiary), capped at Rs. 25 crore per financial year for FY 2024-25 and FY 2025-26, involving sale of assets including investments in shares. E-voting window is August 16–18, 2025, with cut-off date of August 12, 2025.

Likely market impact

This is largely a routine AGM notice, but investors should note two key items: the Rs. 25 crore material related party transaction cap with the material subsidiary Bloom Healthcare, and the regularization of two new independent directors. The RPT approval requires shareholder majority and signals intra-group asset movement. New independent director appointments may modestly strengthen board composition. Overall, no major corporate action signal — stock impact expected to be neutral.